CVS Health (CVS) Rises Higher Than Market: Key Facts
CVS Stock Gains From Its Birth Control Prescribing Service Launch
CVS Pharmacy Launches Birth Control Prescribing in Massachusetts
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
Industry insiders: Trump's tariff plan will cause transportation costs to soar, just like in 2018.
Industry insiders in the shipping and retail industry have warned that Trump's plan to increase import tariffs after returning to the White House will cause a surge in freight prices and exacerbate inflation, just as he did when he was president before. Xeneta's data shows that after the Trump administration announced new tariffs in 2018, prices in the marine container transportation market soared by over 70%.
Stock Market Acts Like a Winner Has Been Declared in the Harris-Trump Debate
Wall Street Today | Market Pulls a Major Rebound After Falling to Start Wednesday
UnitedHealth Follows Competitors, Replaces Humira With Lower-Cost Biosimilars
CVS Shares Are Trading Lower Wednesday: What You Need To Know
CVS Health Stock: Is CVS Underperforming the Healthcare Sector?
Behind the Scenes of CVS Health's Latest Options Trends
Unusual Options Activity: CVS, USB and Others Attract Market Bets, CVS V/OI Ratio Reaches 375.4
Express News | Health Insurers Fall After Bets on Harris Win Rise After Debate
Express News | UnitedHealth Down 2.95%, CVS Down 3.2%, Humana Down 5.5%
American Lung Association and CVS Health Foundation Collaborate to Address and Educate Communities on Health Impacts of Poor Air Quality
Express News | CVS Health-CVS Caremark Enabling Pharmacy Claims for 1-Time Emergency Refills of 10-Day Medication Supply for Members in Storm Francine Impacted Areas
CVS Health Supporting Customers, Patients, Members and Colleagues as Tropical Storm Francine Approaches
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
UnitedHealth Joins Cigna, CVS in Removing AbbVie's Humira From Formularies: Report
Express News | Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $62 Price Target